Case mock-ups bring QbD to life

Mock implementations of quality by design processes, based on actual projects underway, may help bridge the gap between big pharma companies that have the resources to participate in its development and smaller players waiting for signs that QbD will work for them. The implementations were presented at a meeting hosted by the Parenteral Drug Association and EFPIA, the European drug industry association. Article

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.